The United Kingdom has approved Nuvaxovid, the COVID-19 vaccine developed by Novavax, for children aged 12-17, the UK Medicines and Healthcare Products Regulatory Agency (MHRA) said on Friday
LONDON - Britain, the first country to approve a coronavirus vaccine in late 2020, has now also given the first green light to a variant-adapted shot that targets both the original and Omicron version of the virus. The UK medicines regulator (MHRA) gave the so-called bivalent vaccine made by US drug company Moderna conditional approval as a booster for adults.
Britain, the first country to approve a coronavirus vaccine in late 2020, has now also given the first green light to a variant-adapted shot that targets both the original and Omicron version of the